IRIS UniCatt

Cenci, Tonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.241
EU - Europa 3.339
AS - Asia 3.098
SA - Sud America 506
AF - Africa 91
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.146
DE - Germania 1.346
SG - Singapore 1.246
CN - Cina 1.045
SE - Svezia 513
BR - Brasile 423
IT - Italia 340
VN - Vietnam 238
FR - Francia 235
UA - Ucraina 216
GB - Regno Unito 166
IE - Irlanda 132
IN - India 116
PL - Polonia 106
ID - Indonesia 83
FI - Finlandia 82
RU - Federazione Russa 61
TR - Turchia 60
JP - Giappone 55
BD - Bangladesh 51
HK - Hong Kong 49
MX - Messico 42
IQ - Iraq 34
CA - Canada 30
AR - Argentina 28
NL - Olanda 28
ZA - Sudafrica 28
ES - Italia 24
BE - Belgio 20
EC - Ecuador 16
IR - Iran 15
LT - Lituania 15
AT - Austria 14
MA - Marocco 13
CI - Costa d'Avorio 12
PK - Pakistan 12
KR - Corea 11
SA - Arabia Saudita 11
VE - Venezuela 10
TN - Tunisia 9
CL - Cile 8
JM - Giamaica 8
UZ - Uzbekistan 8
CH - Svizzera 7
CO - Colombia 7
NP - Nepal 7
PH - Filippine 7
AZ - Azerbaigian 6
DZ - Algeria 6
KE - Kenya 6
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ET - Etiopia 4
EU - Europa 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
RO - Romania 4
CZ - Repubblica Ceca 3
GE - Georgia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 11.275
Salva come PNG Salva come JPEG
Città #
Ashburn 827
Singapore 701
Chandler 494
San Jose 345
Hangzhou 314
Beijing 183
Dublin 132
Jacksonville 132
Los Angeles 116
San Mateo 107
Nanjing 100
New York 96
Nürnberg 92
Ho Chi Minh City 87
Warsaw 87
Wilmington 84
Ann Arbor 83
Jakarta 75
Lauterbourg 74
Woodbridge 71
Houston 68
The Dalles 67
Dearborn 61
Fairfield 57
Seattle 57
Cattolica 49
Hanoi 49
Munich 49
Izmir 47
Frankfurt am Main 46
Milan 45
Hong Kong 44
Rome 44
Tokyo 44
Chicago 42
Nanchang 42
Boston 41
Helsinki 36
Moscow 36
Hefei 35
Lawrence 35
Princeton 33
São Paulo 33
Bremen 29
Hyderabad 29
Redwood City 29
Council Bluffs 26
Kunming 26
Redmond 25
Marseille 24
Orem 24
Santa Clara 24
Shanghai 23
Stockholm 22
Paris 20
Shenyang 19
Dallas 18
Lancaster 18
Mountain View 18
Brussels 17
Buffalo 17
Denver 17
Johannesburg 16
Cambridge 15
Guangzhou 15
Hebei 15
London 15
Baghdad 14
Boardman 14
Norwalk 14
Tianjin 14
Jiaxing 13
Abidjan 12
Changsha 12
Phoenix 12
Atlanta 11
Haiphong 11
Kraków 11
Leawood 11
Nuremberg 11
Poplar 11
Porto Alegre 11
Seoul 11
Brooklyn 10
Dhaka 10
Kent 10
Manchester 10
Memphis 10
Rio de Janeiro 10
Zhengzhou 10
Augusta 9
Chennai 9
Düsseldorf 9
Fremont 9
Mexico City 9
Montreal 9
Mumbai 9
Naples 9
North Bergen 9
University Park 9
Totale 6.114
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 616
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 511
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 400
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 322
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 307
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 254
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
Von hippel-lindau disease and erythrocytosis 209
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 188
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 185
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 184
PDGFRA-mutant syndrome 182
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 174
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 172
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 171
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 170
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 163
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 161
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 160
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 148
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 148
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 145
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 145
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 143
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 141
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 141
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 140
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 139
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 139
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 137
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 136
Methylation study of the Paris system for reporting urinary (TPS) categories 135
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 132
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 131
The mutant JAK2 allele burden in children with essential thrombocythemia 130
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 129
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 129
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 128
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 127
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 124
Divergent gastrointestinal stromal tumors in syndromic settings 124
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 123
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 123
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 122
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 121
Telomerase inhibition in malignant gliomas. A systematic review 119
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 119
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 116
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 114
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 114
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 112
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 111
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 110
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 108
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 107
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 107
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 103
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 103
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 102
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 101
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 99
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 99
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 99
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 99
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 96
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 95
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 95
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 94
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 93
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 86
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 79
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 73
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 72
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 67
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 60
Totale 11.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.898
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022661 70 42 16 64 57 20 16 96 28 45 87 120
2022/20231.344 196 198 101 208 93 159 54 85 155 28 47 20
2023/20241.116 27 203 25 50 16 92 265 261 6 30 65 76
2024/20251.277 32 29 119 40 106 51 44 55 179 145 255 222
2025/20263.530 490 121 193 432 660 191 659 171 236 231 111 35
Totale 11.403